The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Betadren     1-naphthalen-1-yloxy-3- (propan-2...

Synonyms: Anaprilin, Dociton, Inderal, Obsidan, Obzidan, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Avlocardyl


Psychiatry related information on Avlocardyl


High impact information on Avlocardyl


Chemical compound and disease context of Avlocardyl


Biological context of Avlocardyl


Anatomical context of Avlocardyl


Associations of Avlocardyl with other chemical compounds


Gene context of Avlocardyl


Analytical, diagnostic and therapeutic context of Avlocardyl


  1. Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta. Gidding, S.S., Rocchini, A.P., Beekman, R., Szpunar, C.A., Moorehead, C., Behrendt, D., Rosenthal, A. N. Engl. J. Med. (1985) [Pubmed]
  2. Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis. Lebrec, D., Bernuau, J., Rueff, B., Benhamou, J.P. N. Engl. J. Med. (1982) [Pubmed]
  3. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. Roberts, R., Croft, C., Gold, H.K., Hartwell, T.D., Jaffe, A.S., Muller, J.E., Mullin, S.M., Parker, C., Passamani, E.R., Poole, W.K. N. Engl. J. Med. (1984) [Pubmed]
  4. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. Lebrec, D., Poynard, T., Hillon, P., Benhamou, J.P. N. Engl. J. Med. (1981) [Pubmed]
  5. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. Forfar, J.C., Muir, A.L., Sawers, S.A., Toft, A.D. N. Engl. J. Med. (1982) [Pubmed]
  6. Propranolol for akathisia. Wilbur, R., Kulik, A.V. Lancet (1983) [Pubmed]
  7. Benzodiazepine withdrawal symptoms and propranolol. Tyrer, P., Rutherford, D., Huggett, T. Lancet (1981) [Pubmed]
  8. Diazepam and propranolol in panic disorder and agoraphobia. Noyes, R., Anderson, D.J., Clancy, J., Crowe, R.R., Slymen, D.J., Ghoneim, M.M., Hinrichs, J.V. Arch. Gen. Psychiatry (1984) [Pubmed]
  9. Propranolol in chronic anxiety disorders. A controlled study. Kathol, R.G., Noyes, R., Slymen, D.J., Crowe, R.R., Clancy, J., Kerber, R.E. Arch. Gen. Psychiatry (1980) [Pubmed]
  10. Evaluation of propranolol in opiate dependence. Resnick, R.B., Kestenbaum, R.S., Schwartz, L.K., Smith, A. Arch. Gen. Psychiatry (1976) [Pubmed]
  11. Reversal of catabolism by beta-blockade after severe burns. Herndon, D.N., Hart, D.W., Wolf, S.E., Chinkes, D.L., Wolfe, R.R. N. Engl. J. Med. (2001) [Pubmed]
  12. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. Sarin, S.K., Lamba, G.S., Kumar, M., Misra, A., Murthy, N.S. N. Engl. J. Med. (1999) [Pubmed]
  13. Beta-adrenergic mechanisms in action tremor. Young, R.R., Growdon, J.H., Shahani, B.T. N. Engl. J. Med. (1975) [Pubmed]
  14. Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone. Woods, J.W., Pittman, A.W., Pulliam, C.C., Werk, E.E., Waider, W., Allen, C.A. N. Engl. J. Med. (1976) [Pubmed]
  15. Carbimazole and the autoimmune response in Graves' disease. McGregor, A.M., Petersen, M.M., McLachlan, S.M., Rooke, P., Smith, B.R., Hall, R. N. Engl. J. Med. (1980) [Pubmed]
  16. Potassium iodide and propranolol in Graves' disease. Feely, J. N. Engl. J. Med. (1980) [Pubmed]
  17. Adrenergic modulation of extrarenal potassium disposal. Rosa, R.M., Silva, P., Young, J.B., Landsberg, L., Brown, R.S., Rowe, J.W., Epstein, F.H. N. Engl. J. Med. (1980) [Pubmed]
  18. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. Zhou, H.H., Koshakji, R.P., Silberstein, D.J., Wilkinson, G.R., Wood, A.J. N. Engl. J. Med. (1989) [Pubmed]
  19. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. White, H.D., Norris, R.M., Brown, M.A., Takayama, M., Maslowski, A., Bass, N.M., Ormiston, J.A., Whitlock, T. N. Engl. J. Med. (1987) [Pubmed]
  20. Propranolol for thyroid storm. Hellman, R., Kelly, K.L., Mason, W.D. N. Engl. J. Med. (1977) [Pubmed]
  21. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. Pascal, J.P., Cales, P. N. Engl. J. Med. (1987) [Pubmed]
  22. Beta-adrenoceptor activation mediates stress-induced secretion of beta-endorphin-related peptides from intermediate but not anterior pituitary. Berkenbosch, F., Tilders, F.J., Vermes, I. Nature (1983) [Pubmed]
  23. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Tackett, R.L., Webb, J.G., Privitera, P.J. Science (1981) [Pubmed]
  24. Bronchodilatation: noncholinergic, nonadrenergic mediation demonstrated in vivo in the cat. Irvin, C.G., Boileau, R., Tremblay, J., Martin, R.R., Macklem, P.T. Science (1980) [Pubmed]
  25. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? Taylor, S.H., Silke, B., Lee, P.S. N. Engl. J. Med. (1982) [Pubmed]
  26. Reduction of liver blood flow and propranolol metabolism by cimetidine. Feely, J., Wilkinson, G.R., Wood, A.J. N. Engl. J. Med. (1981) [Pubmed]
  27. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. Piafsky, K.M., Borgá, O., Odar-Cederlöf, I., Johansson, C., Sjöqvist, F. N. Engl. J. Med. (1978) [Pubmed]
  28. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. Pettinger, W.A., Mitchell, H.C. N. Engl. J. Med. (1975) [Pubmed]
  29. Comparative proteomic analysis of extracellular proteins reveals secretion of T-kininogen from vascular smooth muscle cells in response to incubation with s-enantiomer of propranolol. Sui, J., Zhang, J., Ching, C.B., Chen, W.N. Mol. Pharm. (2008) [Pubmed]
  30. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. Le Tulzo, Y., Shenkar, R., Kaneko, D., Moine, P., Fantuzzi, G., Dinarello, C.A., Abraham, E. J. Clin. Invest. (1997) [Pubmed]
  31. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Azzi, M., Charest, P.G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., Piñeyro, G. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  32. Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level. Bakopanos, E., Silva, J.E. Diabetes (2000) [Pubmed]
  33. Lipopolysaccharide-induced Cyclooxygenase-2 Expression in Human U937 Macrophages Is Phosphatidic Acid Phosphohydrolase-1-dependent. Grkovich, A., Johnson, C.A., Buczynski, M.W., Dennis, E.A. J. Biol. Chem. (2006) [Pubmed]
  34. Drug therapy: Propranolol. Shand, D.G. N. Engl. J. Med. (1975) [Pubmed]
  35. Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation. Toft, A.D., Irvine, W.J., Sinclair, I., McIntosh, D., Seth, J., Cameron, E.H. N. Engl. J. Med. (1978) [Pubmed]
WikiGenes - Universities